insights_auto
Waarom is AQB gestegen 3,38%?
Meer informatiechevron_right
AQB:NASDAQ
AquaBounty Technologies
US$ 0,90
arrow_upward
+3,38%(+0,029) 1D
13 nov, 16:00:00 GMT-5 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor AQB genereren…
Openen
US$ 0,85
Hoog
US$ 0,92
Laag
US$ 0,85
Beursw.
11,96 mln.
Gem. vol.
70,12K
Volume
16,47K
52 wk hoog
US$ 1,64
52 wk laag
US$ 0,77
WPA
US$ -4,58
Bèta
1,45
Uitstaande aandelen
13,29 mln.
Aantal medewerkers
3
Openen
US$ 0,85
Hoog
US$ 0,92
Laag
US$ 0,85
Beursw.
11,96 mln.
Gem. vol.
70,12K
Volume
16,47K
52 wk hoog
US$ 1,64
52 wk laag
US$ 0,77
WPA
US$ -4,58
Bèta
1,45
Uitstaande aandelen
13,29 mln.
Aantal medewerkers
3
Nieuwsartikelen
Van webbronnen en nieuwspartners
TradingView
·
6 uur geleden
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
24/7 Wall St.
·
2 uur geleden
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Bloomberg.com
·
11 uur geleden
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Traders Union
·
6 uur geleden
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profiel
AquaBounty Technologies is a biotechnology and aquaculture company based in Maynard, Massachusetts, United States. The company is notable for its research and development of genetically modified fish. It aims to create products that aim to increase the productivity of aquaculture. As of 2020, sale of the company's AquAdvantage salmon has been approved in Canada and the United States. The company sold all of its operating farms and ceased fish production in 2024. Wikipedia
Over AquaBounty Technologies
CEO-
Medewerkers3
Opgericht1991
HoofdkantoorHarvard, Massachusetts, Verenigde Staten
SectorHealth Care
Industrie-
Websiteaquabounty.com